Home
Investment
News & Views
Company News
news storage
TechMARK movers: Ark shares recover
Wed, 08 Feb, 2012
INVESTMENT NEWS
Company Search
Search QCK.COM
Investment Home
News & Views
Top Stories
Charting
Company Search
Watchlist
Market Reports
Market Buzz
Company News
Economic News
New Issues
Other News
TechMARK movers: Ark shares recover
Wed, 10 Mar 2010, 16:52:00
ARK Therapeutics
has made back some of yesterday's loss after the publication of its 2009 figures. The drug developer reported an increase in its loss from £17.6m to £21.2m. Ark still has net cash of £20.7m and this should last until the second half of 2011. Ark says that it has decided to put the development of Vitor on hold. Ark is carrying out a strategic review of the business and is prepared to consider any bids. The sale of 450 shares just before 3pm appears to have had an excessive effect on the
Skyepharma
share price. Shares in the drug developer were unchanged prior to the £284 deal but they fell a few minutes afterwards.
FTSE TechMARK - Risers
Corin Group (CRG) 62.00p +5.08% Trafficmaster (TFC) 35.00p +4.48% Phytopharm (PYM) 11.25p +4.44% Ark Therapeutics (AKT) 12.00p +4.35% DRS Data (DRS) 12.50p +4.00% Morse (MOR) 39.25p +3.97% Sinclair Pharma (SPH) 31.00p +3.33% Alterian (ALN) 150.75p +3.25% Intec Telecom Systems (ITL) 95.50p +3.24% Sepura (SEPU) 48.00p +3.23%
FTSE TechMARK - Fallers
Skyepharma (SKP) 63.00p -4.55% Asterand (ATD) 17.75p -4.23% Vislink (VLK) 26.00p -2.88% Kewill (KWL) 103.00p -2.83% Dialight (DIA) 250.00p -2.82% Parity Group (PTY) 9.75p -2.50% Puricore (PURI) 11.00p -2.27% Emblaze (BLZ) 43.75p -2.23% Innovation Group (TIG) 12.75p -1.92% NXT (NTX) 13.50p -1.82%
©2004-2009 QCK.com